摘要 |
The present invention relates to a novel methanone derivative, a preparation method for same, and a pharmaceutical composition, for preventing or treating retinal diseases, containing same as an active ingredient. A novel methanone derivative, an optical isomer of same, or pharmaceutically acceptable salts of same, according to the present invention, has excellent inhibitory efficiency of receptor-interacting serine/threonine-protein kinase 1 (RIPK1). Therefore, a composition containing same as an active ingredient can be utilized as a pharmaceutical composition for preventing or treating retinal diseases such as retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardts disease, Usher syndrome, choroideremia, rod-cone or cone-rod dystrophy, ciliopathy, mitochondrial disorders, progressive retinal atrophy, degenerative retinal diseases, age-related macular degeneration (AMD), wet AMD, dry AMD, geographical atrophy, inherited or acquired macular degeneration, retinal photoreceptor diseases, retinal pigment epithelial diseases, diabetic retinopathy, cystic macular edema, uveitis, retinal detachment, traumatic retinal injury, iatrogenic retinal injury, macular holes, macular capillarectasia, ganglion cell diseases, optic nerve diseases, glaucoma, optic neuropathy, ischemic retinal diseases, retinopathy of prematurity, occlusion of retinal vessels, inherited macroaneurysm, retinal vascular diseases, ophthalmic vascular diseases, glaucomatous retinal neurodegeneration, ischemic optic neuropathy and the like. |
申请人 |
THE INDUSTRY & ACADEMIC COOPERATION IN CHUNGNAM NATIONAL UNIVERSITY (IAC) |
发明人 |
KIM, EUNHEE;YOO, SUNG-EUN;KANG, NAM SOOK;KOO, TAE-SUNG;PARK, MIN-YOUNG;KIM, YOUNG-HOON;BAE, HYUN-JU;KIM, JIN-WOO;IN, TAE-KYU;JOO, CHOUN-KI |